NO884497L - Dideoksycytidin-derivater. - Google Patents
Dideoksycytidin-derivater.Info
- Publication number
- NO884497L NO884497L NO88884497A NO884497A NO884497L NO 884497 L NO884497 L NO 884497L NO 88884497 A NO88884497 A NO 88884497A NO 884497 A NO884497 A NO 884497A NO 884497 L NO884497 L NO 884497L
- Authority
- NO
- Norway
- Prior art keywords
- dideoxycytidine
- didehydro
- cytidine
- methylene
- dideoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10722187A | 1987-10-09 | 1987-10-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO884497D0 NO884497D0 (no) | 1988-10-07 |
| NO884497L true NO884497L (no) | 1989-04-10 |
Family
ID=22315505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO88884497A NO884497L (no) | 1987-10-09 | 1988-10-07 | Dideoksycytidin-derivater. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0311100A3 (fr) |
| JP (1) | JPH01132597A (fr) |
| KR (1) | KR890006624A (fr) |
| AU (1) | AU2355488A (fr) |
| DK (1) | DK564088A (fr) |
| FI (1) | FI884627L (fr) |
| HU (1) | HU201090B (fr) |
| IL (1) | IL87949A0 (fr) |
| MC (1) | MC1982A1 (fr) |
| NO (1) | NO884497L (fr) |
| NZ (1) | NZ226481A (fr) |
| PT (1) | PT88716B (fr) |
| YU (1) | YU187788A (fr) |
| ZA (1) | ZA886890B (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
| US6448392B1 (en) | 1985-03-06 | 2002-09-10 | Chimerix, Inc. | Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use |
| NZ223910A (en) * | 1987-03-20 | 1991-02-26 | Bristol Myers Co | 2',3'-dideoxynucleosides, process for their production and intermediates therefor |
| US5631370A (en) * | 1988-01-20 | 1997-05-20 | Regents Of The University Of Minnesota | Optically-active isomers of dideoxycarbocyclic nucleosides |
| US6252060B1 (en) | 1988-07-07 | 2001-06-26 | Nexstar Pharmaceuticals, Inc. | Antiviral liponucleosides: treatment of hepatitis B |
| US5817638A (en) * | 1988-07-07 | 1998-10-06 | Nexstar Pharmaceuticals, Inc. | Antiviral liponucleosides: treatment of hepatitis B |
| US6599887B2 (en) | 1988-07-07 | 2003-07-29 | Chimerix, Inc. | Methods of treating viral infections using antiviral liponucleotides |
| GB8823320D0 (en) * | 1988-10-05 | 1988-11-09 | Nycomed As | Chemical compounds |
| EP0500610A1 (fr) * | 1989-11-06 | 1992-09-02 | Nycomed Imaging As | Derives de nucleosides |
| US5192764A (en) * | 1991-05-30 | 1993-03-09 | Research Foundation Of State Of N.Y. | Pyrazinone n-oxide nucleosides and analogs thereof |
| RU2085557C1 (ru) * | 1991-09-30 | 1997-07-27 | Санкио Компани Лимитед | Производные нуклеозидов пиримидина или их фармацевтически приемлемые соли и способ их получения |
| US6576636B2 (en) | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
| US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
| AU1412299A (en) * | 1997-11-25 | 1999-06-15 | Protarga, Inc. | Nucleoside analog compositions and uses thereof |
| JP4634694B2 (ja) | 2001-03-23 | 2011-02-16 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | 脂肪アルコール薬物複合体 |
| US8552054B2 (en) | 2001-03-23 | 2013-10-08 | Luitpold Pharmaceuticals, Inc. | Fatty amine drug conjugates |
| EP1569652A4 (fr) | 2001-12-14 | 2008-07-02 | Pharmasset Inc | Nucleosides n sp 4 /sp -acylcytosines pour le traitement d'infections virales |
| US9326983B2 (en) | 2013-08-01 | 2016-05-03 | University Of Kentucky Research Foundation | Compositions and methods for treating retinal degradation |
| DK3261644T3 (da) * | 2015-02-26 | 2021-06-28 | Univ Kentucky Res Found | Sammensætninger og fremgangsmåder til behandling af nethindenedbrydning |
| US11219623B2 (en) | 2015-02-26 | 2022-01-11 | University Of Kentucky Research Foundation | Inflammasome inhibition for the treatment of Parkinson's disease, Alzheimer's disease and multiple sclerosis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ216172A (en) * | 1985-05-15 | 1989-08-29 | Wellcome Found | Nucleosides and pharmaceutical compositions |
| DE3850571T2 (de) * | 1987-03-24 | 1994-10-27 | Nycomed Imaging As | 2',3'-dideoxyribofuranoxid-derivate. |
| EP0294113A1 (fr) * | 1987-05-29 | 1988-12-07 | The Wellcome Foundation Limited | Nucléosides thérapeutiques |
| US4837311A (en) * | 1987-06-22 | 1989-06-06 | Hoffman-La Roche Inc. | Anti-retroviral compounds |
-
1988
- 1988-09-15 ZA ZA886890A patent/ZA886890B/xx unknown
- 1988-10-06 NZ NZ226481A patent/NZ226481A/xx unknown
- 1988-10-06 IL IL87949A patent/IL87949A0/xx unknown
- 1988-10-07 AU AU23554/88A patent/AU2355488A/en not_active Abandoned
- 1988-10-07 YU YU01877/88A patent/YU187788A/xx unknown
- 1988-10-07 EP EP19880116655 patent/EP0311100A3/fr not_active Withdrawn
- 1988-10-07 KR KR1019880013065A patent/KR890006624A/ko not_active Withdrawn
- 1988-10-07 PT PT88716A patent/PT88716B/pt not_active IP Right Cessation
- 1988-10-07 MC MC882009A patent/MC1982A1/fr unknown
- 1988-10-07 FI FI884627A patent/FI884627L/fi not_active IP Right Cessation
- 1988-10-07 DK DK564088A patent/DK564088A/da not_active Application Discontinuation
- 1988-10-07 NO NO88884497A patent/NO884497L/no unknown
- 1988-10-07 HU HU885191A patent/HU201090B/hu not_active IP Right Cessation
- 1988-10-08 JP JP63254668A patent/JPH01132597A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI884627A0 (fi) | 1988-10-07 |
| DK564088A (da) | 1989-04-10 |
| DK564088D0 (da) | 1988-10-07 |
| MC1982A1 (fr) | 1989-11-23 |
| PT88716B (pt) | 1992-12-31 |
| NZ226481A (en) | 1992-01-29 |
| AU2355488A (en) | 1989-04-13 |
| YU187788A (en) | 1990-04-30 |
| EP0311100A3 (fr) | 1990-10-31 |
| EP0311100A2 (fr) | 1989-04-12 |
| IL87949A0 (en) | 1989-03-31 |
| NO884497D0 (no) | 1988-10-07 |
| ZA886890B (en) | 1989-05-30 |
| HU201090B (en) | 1990-09-28 |
| KR890006624A (ko) | 1989-06-14 |
| HUT47592A (en) | 1989-03-28 |
| FI884627A7 (fi) | 1989-04-10 |
| FI884627L (fi) | 1989-04-10 |
| JPH01132597A (ja) | 1989-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2144027C1 (ru) | Изохинолины, способ их получения и фармацевтическая композиция на их основе | |
| HU201090B (en) | Process for producing dideoxocytidine derivatives and pharmaceutical compositions comprising same as active ingredient | |
| IL128652A (en) | History of adenosine substituted N6 heterocyclic and pharmaceutical preparations containing them | |
| JP2007526291A (ja) | アデノシン受容体アゴニスト | |
| IE49701B1 (en) | Amides of acyl-carnitines,process for preparing same and pharmaceutical compositions containing such amides | |
| NO144211B (no) | Analogifremgangsmaate til fremstilling av nye tyrosinderivater med farmasoeytisk virkning paa glatte muskler | |
| CN115960148B (zh) | 一种新型的胞苷衍生物及其药物组合物和用途 | |
| JPS6229566A (ja) | 新規グアニジノメチル安息香酸誘導体 | |
| US4315920A (en) | Adenosine deaminase inhibitors | |
| JPH02124884A (ja) | N―置換アミド誘導体 | |
| US3956277A (en) | Purine sugar derivatives | |
| JP3885900B2 (ja) | ベンゾピラン誘導体及びそれを有効成分とする心臓疾患治療剤 | |
| PT100216B (pt) | N-{{4,5-di-hidroxi- e 4,5,8-tri-hidroxi-9,10-di-hidro-9,10-dioxo-2-antracentil} carbonil}-aminoacidos uteis na terapia de afeccoes osteoarticulares, processo para a sua preparacao e composicoes farmaceuticas que os contem | |
| US4086416A (en) | Septacidin analogs | |
| HU180617B (en) | Process for producing 1,2-bis-bracket-nicotinamido-bracket closed-propane,salts and pharmaceutical compositions containing them | |
| Wu et al. | Discovery, synthesis, and biological mechanism evaluation of novel quinoline derivatives as potent NLRP3 inhibitors | |
| CN117343072B (zh) | 一种1-取代肉桂酰基-2-氧代石蒜碱类化合物及其制备方法和应用 | |
| US4539402A (en) | Quinazolinone derivatives | |
| SK146096A3 (en) | Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them | |
| KR870001935B1 (ko) | 항포진성을 갖는 뉴클레오시 유도체 및 그의 산부가염의 제조방법 | |
| CN104211748B (zh) | 6‑羟基双脱氧鸟嘌呤核苷磷酸酯制备和用途 | |
| US4992446A (en) | Tricyclic quinolizine amides | |
| FI70019C (fi) | Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara och isynnerhet vid behandling av psoriasis laempliga poycykliska foereningar och mellanprodukter som anvaends vi d oerfarandet | |
| CA2373015A1 (fr) | Dihydrate derive de purine, medicaments le contenant comme principe actif et intermediaire utilise dans sa preparation | |
| JPS6117832B2 (fr) |